Antibiotics-Basel

Scope & Guideline

Empowering the fight against infectious diseases through innovative research.

Introduction

Immerse yourself in the scholarly insights of Antibiotics-Basel with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2079-6382
PublisherMDPI
Support Open AccessYes
CountrySwitzerland
TypeJournal
Converge2010, from 2012 to 2024
AbbreviationANTIBIOTICS-BASEL / Antibiotics-Basel
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Antibiotics-Basel' focuses on the multifaceted field of antibiotic research, encompassing various aspects of antimicrobial resistance, novel therapies, and the implications of antibiotic use across different settings. The journal aims to provide a comprehensive platform for researchers to share innovative findings that contribute to understanding and combating antibiotic resistance, improving patient outcomes, and enhancing public health.
  1. Antimicrobial Resistance Mechanisms:
    Research on the genetic, biochemical, and environmental factors contributing to the emergence and spread of antimicrobial resistance genes in various microbial populations.
  2. Novel Antimicrobial Agents:
    Development and evaluation of new antibiotics, including synthetic compounds, natural products, and their mechanisms of action against resistant pathogens.
  3. Antibiotic Stewardship Practices:
    Studies evaluating the effectiveness of antimicrobial stewardship programs in hospitals and community settings to optimize antibiotic use and reduce resistance.
  4. Clinical Outcomes and Pharmacokinetics:
    Research on the pharmacokinetics and pharmacodynamics of antibiotics, including dosing strategies and their impact on clinical outcomes in various populations.
  5. Environmental Impact of Antibiotics:
    Exploration of antibiotic residues in the environment and their role in selecting for resistant strains, including studies on wastewater treatment and agricultural runoff.
  6. One Health Approach to Antibiotic Use:
    Interdisciplinary research that addresses antibiotic resistance across human, animal, and environmental health sectors, emphasizing the interconnectedness of these fields.
The journal 'Antibiotics-Basel' is witnessing significant growth in specific research areas, reflecting current challenges and advancements in the field of antimicrobial resistance and therapy. The following emerging themes highlight the latest trends and priorities in antibiotic research.
  1. Phage Therapy and Alternative Treatments:
    An increasing number of studies are exploring bacteriophage therapy as a viable alternative to traditional antibiotics, especially for multi-drug-resistant infections.
  2. Environmental Antibiotic Resistance Studies:
    There is a growing focus on understanding the environmental factors contributing to the spread of antibiotic resistance, including studies on wastewater treatment and agricultural practices.
  3. Machine Learning and AI in Antibiotic Research:
    The integration of artificial intelligence and machine learning techniques to predict antibiotic resistance patterns and optimize treatment protocols is emerging as a significant trend.
  4. Antimicrobial Peptides (AMPs):
    Research into the development and application of antimicrobial peptides as novel therapeutic agents against resistant pathogens is gaining momentum.
  5. Impact of Antibiotic Stewardship on Clinical Outcomes:
    There is an increasing emphasis on evaluating the real-world impact of antimicrobial stewardship programs on patient outcomes and healthcare costs.
  6. Resistance Mechanisms in Emerging Pathogens:
    A trend towards investigating resistance mechanisms in new and emerging pathogens, particularly in the context of zoonotic diseases and public health implications.

Declining or Waning

While 'Antibiotics-Basel' has a broad and evolving scope, certain themes appear to be declining in prominence based on recent publication trends. This section highlights these waning areas of focus, which may reflect shifts in research priorities or emerging challenges in the field.
  1. Traditional Antibiotic Usage Studies:
    There has been a noticeable decrease in studies solely focused on traditional antibiotic usage patterns without integrating newer approaches or technologies.
  2. Single-Agent Antibiotic Efficacy Studies:
    Research focusing exclusively on the efficacy of single antibiotics is waning as there is a growing emphasis on combination therapies and multi-drug approaches to combat resistance.
  3. Basic Research on Antibiotic Mechanisms:
    While still relevant, the focus on purely mechanistic studies of antibiotics is declining in favor of translational research that bridges laboratory findings with clinical applications.
  4. Antibiotic Resistance in Non-Clinical Settings:
    There is a noticeable decrease in studies addressing antibiotic resistance in non-clinical environments, such as community settings outside hospitals, as the focus shifts towards clinical implications and hospital-acquired infections.

Similar Journals

Pneumonia

Connecting Researchers to Combat Respiratory Diseases
Publisher: BMCISSN: 2200-6133Frequency: 1 issue/year

Pneumonia is an esteemed open-access journal published by BMC, focusing on a comprehensive range of topics related to pneumonia and respiratory diseases. Since its inception in 2012, the journal has been dedicated to disseminating high-quality research that advances scientific understanding and clinical practices in the field. With an ISSN of 2200-6133, this journal provides researchers, healthcare professionals, and students with immediate access to groundbreaking studies, systematic reviews, and clinical guidelines that address the global challenges posed by pneumonia. By facilitating the open exchange of knowledge, Pneumonia significantly contributes to the enhancement of patient care and the development of effective treatment strategies. Situated in the heart of London, Pneumonia harnesses the strengths of the BMC platform to maintain high academic standards and reach a diverse international audience.

JOURNAL OF BIOMEDICAL SCIENCE

Leading the way in biomedical research and collaboration.
Publisher: BMCISSN: 1021-7770Frequency: 1 issue/year

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Surgical Infections

Fostering interdisciplinary dialogue on infection prevention.
Publisher: MARY ANN LIEBERT, INCISSN: 1096-2964Frequency: 10 issues/year

Surgical Infections, published by MARY ANN LIEBERT, INC, is an esteemed journal dedicated to advancing the understanding and management of infections associated with surgical procedures. With an ISSN of 1096-2964 and an E-ISSN of 1557-8674, this journal has emerged as a vital resource within the fields of Infectious Diseases, Surgery, and Microbiology. Over the years, it has established a notable presence, achieving a 2023 Q2 ranking in Infectious Diseases and Surgery, as well as a Q3 ranking in Microbiology. The journal holds an impressive position at 74th percentile in Surgery according to Scopus, making it a reliable platform for disseminating current research and clinical practices. Surgical Infections aims to provide an interdisciplinary forum for both seasoned professionals and academics, encouraging the exploration of novel therapeutic approaches, prevention strategies, and case studies that address the complexities of surgical-related infections. As the field continues to evolve, this journal remains committed to fostering innovative research that enhances clinical outcomes and patient safety.

International Journal of Microbiology

Innovating Solutions in Medical, Agricultural, and Environmental Microbiology
Publisher: HINDAWI LTDISSN: 1687-918XFrequency: 1 issue/year

Welcome to the International Journal of Microbiology, a premier platform dedicated to the dissemination of cutting-edge research in the field of microbiology. Published by HINDAWI LTD, this open-access journal has been making significant strides since its inception in 2009, ensuring that high-quality research is accessible to all. Situated in Egypt, the journal caters to an international audience, fostering collaboration across borders. With a commendable impact factor and recognized in the Q2 category for both general and medical microbiology, it ranks 48th out of 182 and 40th out of 140, respectively, according to Scopus statistics, placing it among the top-tier journals in its field. The International Journal of Microbiology publishes articles that explore various aspects of microbiology, from fundamental studies to applied research, thus contributing significantly to advancements in medical, agricultural, and environmental microbiology. This journal is an essential resource for researchers, professionals, and students eager to stay at the forefront of microbiological studies and their applications.

INFECTIOUS DISEASES IN CLINICAL PRACTICE

Connecting academia and healthcare for impactful solutions.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1056-9103Frequency: 6 issues/year

INFECTIOUS DISEASES IN CLINICAL PRACTICE, published by Lippincott Williams & Wilkins, is a crucial resource in the field of infectious diseases and microbiology. With an ISSN of 1056-9103 and an E-ISSN of 1536-9943, this journal has been a platform for scholarly communication since its inception in 1992, now spanning over two decades of continuous publication. The journal primarily focuses on the latest research developments, case studies, and clinical practices relevant to infectious diseases, making it an indispensable tool for researchers, healthcare professionals, and students alike. Although it is currently categorized in the Q4 quartile for both Infectious Diseases and Medical Microbiology, it continues to strive for excellence and relevance in a rapidly evolving field. By facilitating open access to impactful articles (note: Open Access not applicable), the journal aims to enhance global understanding and management of infectious diseases, ensuring that practitioners are well-equipped to confront contemporary challenges in this critical area of public health. Situated in the United States at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, INFECTIOUS DISEASES IN CLINICAL PRACTICE plays an essential role in fostering academic discourse and advancing clinical knowledge.

Indonesian Journal of Pharmacy

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: UNIV GADJAH MADA, FAC FARMASIISSN: 2338-9486Frequency: 4 issues/year

Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.

HELICOBACTER

Advancing Gastroenterology Through Innovative Research
Publisher: WILEYISSN: 1083-4389Frequency: 6 issues/year

HELICOBACTER is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of gastroenterology and infectious diseases. With an impressive impact factor that places it in the Q1 quartile across three critical categories—gastroenterology, infectious diseases, and miscellaneous medicine—it signifies the journal's crucial role in disseminating high-quality research and fostering academic dialogue. Commencing publication in 1996, HELICOBACTER has established itself as a pivotal platform for innovative studies, case reports, and reviews, focusing on Helicobacter species and their clinical implications, thus attracting a global audience of researchers, healthcare professionals, and students eager to stay at the forefront of the field. Despite not being an open-access journal, its strong reputation is reinforced by its Scopus ranks, where it stands impressively at #19 out of 167 in gastroenterology, placing it in the 88th percentile among its peers. As a vital resource for those engaged in gastrointestinal and infectious research, HELICOBACTER continues to contribute significantly to the understanding and management of Helicobacter-related conditions.

Microbial Drug Resistance

Elevating Research on the Frontlines of Drug Resistance
Publisher: MARY ANN LIEBERT, INCISSN: 1076-6294Frequency: 10 issues/year

Microbial Drug Resistance, published by MARY ANN LIEBERT, INC, is a pivotal journal that explores the critical intersection of microbiology and pharmacology with a keen focus on antibiotic resistance and related issues. Since its inception in 1995, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for innovative studies that inform the global response to antimicrobial resistance. With a commendable position in the Category Quartiles, ranked Q2 in Medicine (miscellaneous) and Q2 in Pharmacology for 2023, it caters to a multidisciplinary audience by addressing the implications of microbial resistance within various medical contexts. Although currently non-Open Access, the journal allows subscribers and institutions to access high-quality, peer-reviewed research, directly impacting policy and practice in healthcare settings. Committed to advancing our understanding and combating the challenges posed by resistant microbes, Microbial Drug Resistance remains an essential publication in the fields of microbiology, immunology, and pharmacology.

FEMS MICROBIOLOGY LETTERS

Transforming Microbiology Through Concise Scholarship
Publisher: OXFORD UNIV PRESSISSN: 0378-1097Frequency: 1 issue/year

FEMS Microbiology Letters, published by Oxford University Press, is a prestigious international journal dedicated to advancing the understanding of microbiology through concise and impactful research articles. With an ISSN of 0378-1097 and E-ISSN 1574-6968, this journal encompasses a wide range of topics within the fields of genetics, microbiology, and molecular biology, achieving a notable Q3 quartile ranking in these categories as of 2023. As an essential platform for researchers, professionals, and students, FEMS Microbiology Letters invites submissions that contribute valuable insights into microbial behaviors, genetic mechanisms, and innovative methodologies pivotal in the study of microbiology. Although it is not an open-access publication, the journal's rigorous editorial standards ensure high-quality content that is relevant and significant to its audience, furthering scholarly dialogue and collaboration in the vibrant field of microbiological research.

CURRENT MICROBIOLOGY

Fostering Excellence in Microbiological Scholarship
Publisher: SPRINGERISSN: 0343-8651Frequency: 12 issues/year

CURRENT MICROBIOLOGY, published by SPRINGER, is a renowned journal that serves as a critical platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0343-8651 and an E-ISSN of 1432-0991, this journal contributes significantly to the scientific community by covering a diverse range of topics from applied microbiology and biotechnology to various aspects of medicine. Currently operating an impact factor that places it within the Q2 quartile in both applied microbiology and biotechnology and medicine (miscellaneous), along with a Q3 ranking in microbiology, CURRENT MICROBIOLOGY is recognized for its valuable contributions to these dynamic fields. This journal, which has documented the evolution of microbiological research since its inception in 1978, provides an essential venue for researchers, professionals, and students alike to explore innovative studies and advances. Although it does not offer open access, the journal remains a pivotal resource within its category, complementing the ongoing growth and exploration of microbiology from its headquarters at One New York Plaza, Suite 4600, New York, NY 10004, United States. Its Scopus rankings highlight its reputable standing, making it a key publication for anyone aiming to stay at the forefront of microbiological science.